NETHERLANDS - Aescap Venture takes 25% stake in I-Optics
Aescap Venture has taken a 25% stake in Dutch medical technology company i-Optics.
i-Optics produces retinal cameras, which screen for potentially blinding diseases like Diabetic RetinoPathy (DRP) and Macular Degeneration. The company's lead camera product will be tested in the US in a comparative clinical trial involving 1000 patients. Two other diagnostic cameras, one for the use on infants and the other for R&D purposes, are in late stage development.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds
Back to Top








